002262 恩華藥業
按盤價 
21.180 +0.180 (+0.857%)
21.180 +0.180 (+0.857%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.863 | 13.770 | 16.652 | 17.202 | 17.088 |
| 總資產報酬率 ROA (%) | 3.365 | 11.972 | 14.505 | 15.018 | 14.792 |
| 投入資產回報率 ROIC (%) | 3.654 | 13.040 | 15.923 | 16.696 | 16.598 | 邊際利潤分析 |
| 銷售毛利率 (%) | 70.967 | 72.127 | 73.558 | 72.829 | 76.260 |
| 營業利潤率 (%) | 22.182 | 20.286 | 23.458 | 23.452 | 23.344 |
| 息稅前利潤/營業總收入 (%) | 21.996 | 19.558 | 22.458 | 22.798 | 22.546 |
| 淨利潤/營業總收入 (%) | 19.724 | 17.846 | 20.022 | 20.515 | 20.474 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.806 | 97.405 | 99.774 | 96.649 | 94.928 |
| 價值變動淨收益/利潤總額(%) | 5.059 | 5.214 | 5.057 | 4.368 | 3.664 |
| 營業外收支淨額/利潤總額(%) | -0.409 | -2.224 | -3.076 | -1.172 | -1.370 | 償債能力分析 |
| 流動比率 (X) | 5.694 | 5.917 | 5.683 | 6.455 | 5.857 |
| 速動比率 (X) | 5.118 | 5.224 | 5.063 | 5.683 | 4.955 |
| 資產負債率 (%) | 13.452 | 12.960 | 13.821 | 12.528 | 13.847 |
| 帶息債務/全部投入資本 (%) | 4.616 | 4.003 | 4.096 | 1.649 | 0.850 |
| 股東權益/帶息債務 (%) | 2,044.312 | 2,367.971 | 2,309.842 | 5,869.335 | 11,456.128 |
| 股東權益/負債合計 (%) | 645.616 | 674.048 | 625.837 | 700.820 | 626.404 |
| 利息保障倍數 (X) | -230.366 | -68.043 | -74.711 | -59.674 | -46.628 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 90.303 | 90.198 | 79.769 | 66.251 | 62.707 |
| 存貨周轉天數 (天) | 139.766 | 154.934 | 154.132 | 176.733 | 232.955 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 21/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
